208 related articles for article (PubMed ID: 34100683)
1. Pseudo Test-Retest Evaluation of Millimeter-Resolution Whole-Brain Dynamic Contrast-enhanced MRI in Patients with High-Grade Glioma.
Bliesener Y; Lebel RM; Acharya J; Frayne R; Nayak KS
Radiology; 2021 Aug; 300(2):410-420. PubMed ID: 34100683
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
3. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
[TBL] [Abstract][Full Text] [Related]
4. Effects of artery input function on dynamic contrast-enhanced MRI for determining grades of gliomas.
Jia L; Wu X; Wan Q; Wan L; Jia W; Zhang N
Br J Radiol; 2021 Mar; 94(1119):20200699. PubMed ID: 33332981
[TBL] [Abstract][Full Text] [Related]
5. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.
Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ
Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974
[TBL] [Abstract][Full Text] [Related]
6. Evaluating feasibility of high resolution T1-perfusion MRI with whole brain coverage using compressed SENSE: Application to glioma grading.
Sasi S D; Ramaniharan AK; Bhattacharjee R; Gupta RK; Saha I; Van Cauteren M; Shah T; Gopalakrishnan K; Gupta A; Singh A
Eur J Radiol; 2020 Aug; 129():109049. PubMed ID: 32464580
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
[TBL] [Abstract][Full Text] [Related]
8. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
9. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
[TBL] [Abstract][Full Text] [Related]
10. Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.
Di N; Cheng W; Jiang X; Liu X; Zhou J; Xie Q; Chu Z; Chen H; Wang B
J Neuroradiol; 2019 May; 46(3):186-192. PubMed ID: 29752976
[TBL] [Abstract][Full Text] [Related]
11. T1 in high-grade glioma and the influence of different measurement strategies on parameter estimations in DCE-MRI.
Larsson C; Kleppestø M; Grothe I; Vardal J; Bjørnerud A
J Magn Reson Imaging; 2015 Jul; 42(1):97-104. PubMed ID: 25350816
[TBL] [Abstract][Full Text] [Related]
12. Assessing the reproducibility of high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging in patients with gliomas.
Lim WH; Park JS; Park J; Choi SH
Sci Rep; 2021 Dec; 11(1):23217. PubMed ID: 34853347
[TBL] [Abstract][Full Text] [Related]
13. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
Choi HS; Kim AH; Ahn SS; Shin NY; Kim J; Lee SK
Korean J Radiol; 2013; 14(3):487-92. PubMed ID: 23690718
[TBL] [Abstract][Full Text] [Related]
14. Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.
Anzalone N; Castellano A; Cadioli M; Conte GM; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Grillea G; Vitali P; Aquino D; Terreni MR; Torri V; Erickson BJ; Caulo M
Radiology; 2018 Jun; 287(3):933-943. PubMed ID: 29361245
[TBL] [Abstract][Full Text] [Related]
15. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas.
Zhang N; Zhang L; Qiu B; Meng L; Wang X; Hou BL
J Magn Reson Imaging; 2012 Aug; 36(2):355-63. PubMed ID: 22581762
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.
Conte GM; Castellano A; Altabella L; Iadanza A; Cadioli M; Falini A; Anzalone N
Radiol Med; 2017 Apr; 122(4):294-302. PubMed ID: 28070841
[TBL] [Abstract][Full Text] [Related]
17. Accelerated Brain DCE-MRI Using Iterative Reconstruction With Total Generalized Variation Penalty for Quantitative Pharmacokinetic Analysis: A Feasibility Study.
Wang C; Yin FF; Kirkpatrick JP; Chang Z
Technol Cancer Res Treat; 2017 Aug; 16(4):446-460. PubMed ID: 27215931
[TBL] [Abstract][Full Text] [Related]
18. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
[TBL] [Abstract][Full Text] [Related]
19. Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.
Keil VC; Pintea B; Gielen GH; Greschus S; Fimmers R; Gieseke J; Simon M; Schild HH; Hadizadeh DR
J Neurooncol; 2017 May; 133(1):155-163. PubMed ID: 28425048
[TBL] [Abstract][Full Text] [Related]
20. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]